Home
Live Updates
FDA Panel Says No to Experimental ALS Drug : comparemela.com
FDA Panel Says No to Experimental ALS Drug
THURSDAY, Sept. 28, 2023 (HealthDay News) -- An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem cell-based experimental treatment for amyotrophic
Related Keywords
Virginia ,
United States ,
Kenneth Fischbeck ,
Lisa Lee ,
National Institutes Of Neurological Disorders ,
Drug Administration On ,
Associated Press ,
Healthday News ,
Drug Administration ,
Virginia Tech ,
Hereditary Neurological Diseases ,
National Institutes ,
Neurological Disorders ,
Physicians Briefing ,
Medicine ,
Rade ,
Harmacology ,
The Press ,
Enetics ,
Cientific Terms ,
comparemela.com © 2020. All Rights Reserved.